SYNTHESIS OF FLUORO-CONTAINING SUBSTITUTED 1,3,5-TRIAZINES

DOI: 10.1007/BF00953302

Source and publish data:

Bulletin of the Academy of Sciences of the USSR Division of Chemical Science p. 836 - 840 (1989)

Update date:2022-08-05

Topics:

Authors:

Shmel'kova, T. K.

Ignatenko, A. V.

Krukovskii, S. P.

Ponomarenko, V. A.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1007/BF00953302

Full text of DOI:10.1007/BF00953302

Products guided by the article

Product name:2,2,3,3,4,4,5,5,6,6,7,7,7-Tridecafluoro-N-(imino-phenyl-methyl)-heptanamidine

Cas No:123528-68-7

R&D Labs maybe for 123528-68-7

Luoyang Aoda chemical Co.,Ltd.

Contact:+86-379-67518785 67516588

Address:MiaoWan industry district,YanShi City,Henan,China
Antaeus Bio-technology Co., LTD(expird)

Contact:021-31252569

Address:shanghai pudong
Zhangjiagang Jianing Import & Export Co.,Ltd.

Contact:086-512-55379012 13913607595

Address:NO.1 Guotai North Road Zhangjiagang Economic Development Zone,215600,Jiangsu,China
Huzhou City Linghu Xinwang Chemical Co.,Ltd.

Contact:86-572-3948695/3945236

Address:huzhou
Suns Chemical Sdn Bhd

Contact:0086 371 65711996

Address:Jalan 4/3, Kawasan Perindustrian Serendah, 48000 Rawang,

Relevant to this article

Metal-catalyzed reactions between 2-azabicyclo[2.2.1]hept-5-en-3-ones and arylboronic acids

Doi:10.1002/ejoc.201000135
(2010)
Synthesis and biological activity of N-aroyl-tetrahydro-γ-carbolines

Doi:10.1016/j.bmc.2010.04.034
(2010)
Evaluation of 3-(4′-(4″-fluorophenyl)-6′-phenylpyrimidin- 2′-yl)-2-phenylthiazolidin-4-one for in vivo modulation of biomarkers of chemoprevention in the 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis

Doi:10.3109/14756366.2010.525507
(2011)
Novel synthesis of the isoflavone genistein

Doi:10.1055/s-0029-1219757
(2010)
Organocatalyst in Direct C(_sp²)-H Arylation of Unactivated Arenes: [1-(2-Hydroxyethyl)-piperazine]-Catalyzed Inter-/Intra-molecular C-H Bond Activation

Doi:10.1021/acs.joc.0c01019
(2020)
Defining the key pharmacophore elements of PF-04620110: Discovery of a potent, orally-active, neutral DGAT-1 inhibitor

Doi:10.1016/j.bmc.2013.06.045
(2013)

Article Doi